Production (Stage)
NuGen Medical Devices Inc.
NGMD.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.09M | 364.50K | -2.17M | -694.90K | -1.35M |
| Total Depreciation and Amortization | 109.80K | 113.00K | 114.00K | 116.80K | 127.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.65M | -947.00K | 630.60K | 203.40K | 291.70K |
| Change in Net Operating Assets | -123.80K | -1.53M | 769.60K | 217.90K | 331.90K |
| Cash from Operations | -571.00K | -1.99M | -655.10K | -156.80K | -603.30K |
| Capital Expenditure | -- | -7.40K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -300.00 | -300.00 | -300.00 | -300.00 |
| Cash from Investing | -- | -7.70K | -300.00 | -300.00 | -300.00 |
| Total Debt Issued | -- | -10.00M | 10.00M | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | -7.00K | -20.80K |
| Issuance of Common Stock | 60.50K | 10.41M | 65.00K | 0.00 | 765.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 42.20K | 289.30K | 7.38M | -5.10K | 552.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -528.90K | -1.71M | 6.72M | -162.20K | -51.60K |